Zumiez Inc
$378.16M- Market cap
- $304.21M
- Debt
- +$201.82M
- Cash
- −$127.86M
Capital structure 60% equity / 40% debt · EV / Revenue 0.41x · EV / EBITDA 8.34x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $304.21M · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: ZUMZ stock price at discount vs ANIK $18.03 current versus $135.93 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ANIK's multiple
Implied fair value · at ZUMZ's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ZUMZ FY 2026 (ended Jan 31, 2026) · ANIK FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 60% equity / 40% debt · EV / Revenue 0.41x · EV / EBITDA 8.34x
Capital structure 100% equity / -0% debt · EV / Revenue 1.75x
ZUMZ carries the larger enterprise value at $378.16M against $197.18M; ZUMZ trades on the lower EV / Revenue multiple (0.41x vs 1.75x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ZUMIEZ INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Anika Therapeutics, Inc. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.62x
-0.00x
Net debt / EBITDA
Leverage against operating earnings
1.63x
34.65x
Cash and equivalents
Liquid reserves on the balance sheet
$127.86M
$81.17M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ABERCROMBIE & FITCH CO /DE/
ZUMZ vs ANF
AMERICAN EAGLE OUTFITTERS INC
ZUMZ vs AEO
Boot Barn Holdings, Inc.
ZUMZ vs BOOT
Victoria's Secret & Co.
ZUMZ vs VSCO
ZIMMER BIOMET HOLDINGS, INC.
ZUMZ vs ZBH
STRYKER CORP
ZUMZ vs SYK
BECTON DICKINSON & CO
ZUMZ vs BDX
INTEGRA LIFESCIENCES HOLDINGS CORP
ZUMZ vs IART
$201.82M
-$149.00K
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.